INTERNATIONAL PATENT: X4 PHARMACEUTICALS, INC. FILES APPLICATION FOR "TREATMENT OF CONDITIONS RELATED TO CXCR2 LOSS-OF-FUNCTION"

GENEVA, Feb. 11 -- X4 PHARMACEUTICALS, INC. (61 North Beacon Street, 4th FloorBoston, Massachusetts 02134) filed a patent application (PCT/US2025/040119) for "TREATMENT OF CONDITIONS RELATED TO CXCR2 LOSS-OF-FUNCTION" on Jul 31, 2025. With publication no. WO/2026/030589, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TAVERAS, Art (c/o X4 Pharmaceuticals, Inc.61 North Beacon Street, 4th FloorBOSTON, Massachusetts 02134), NGUYEN, Chi (Donaufelder Strasse 115/2/51210 Vienna)

Abstract: The present invention relates to compo...